Postdoc., Tsinghua University
Ph.D., Tsinghua University, 2020
B.S., Hebei Normal University, 2013
Joined JiaLab in 2013
Main interest: By exploring the pathogenesis of ALS, it is expected to discover potential therapeuti c targets.
SineuGene Therapeutics is a biopharmaceutical company focusing on gene therapy for brain
disorders. Founded in late 2021, the company builds on more than a decade of research on
neuroscience by JiaLab at Tsinghua University's School of Medicine.
